RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,770,338 | -0.6% | 8,039,100 | +133.0% | 1.48% | -53.4% |
| Q2 2023 | $3,795,000 | -23.2% | 3,450,000 | -16.9% | 3.18% | -29.0% |
| Q1 2023 | $4,938,500 | -18.2% | 4,150,000 | +2.5% | 4.48% | -29.5% |
| Q4 2022 | $6,034,500 | +86.5% | 4,050,000 | +54.6% | 6.36% | +60.9% |
| Q3 2022 | $3,236,000 | +66.1% | 2,620,000 | +6.9% | 3.95% | +66.2% |
| Q2 2022 | $1,948,000 | -69.2% | 2,450,000 | -30.2% | 2.38% | -56.0% |
| Q1 2022 | $6,318,000 | +15.5% | 3,510,000 | +9.7% | 5.40% | +47.3% |
| Q4 2021 | $5,472,000 | -18.4% | 3,200,000 | -1.7% | 3.67% | -25.5% |
| Q3 2021 | $6,705,000 | +33.8% | 3,255,000 | +50.0% | 4.92% | +45.1% |
| Q2 2021 | $5,013,000 | +220.9% | 2,170,000 | +287.5% | 3.39% | +192.8% |
| Q1 2021 | $1,562,000 | – | 560,000 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |